Clinical Trials Logo

Clinical Trial Summary

The primary objective of this study is to evaluate the effects of enoxaparin on venous thromboembolism incidence and bleeding rate (major and minor bleeding) in patients undergoing curative abdominal cancer surgery. The secondary objective is evaluate the incidence of adverse events of enoxaparin in these patients.


Clinical Trial Description

n/a


Study Design

Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention


Related Conditions & MeSH terms


NCT number NCT00723216
Study type Interventional
Source Sanofi
Contact
Status Completed
Phase Phase 3
Start date March 2007
Completion date December 2007

See also
  Status Clinical Trial Phase
Completed NCT02653469 - Augmented Pulse Pressure Variation to Predict Fluid Responsiveness in Open Laparotomy N/A
Completed NCT04032951 - 22 Gauge Needle for EUS Guided Tissue Acquisition of Samples for Histologic Examination N/A
Completed NCT01399814 - Restricted Intravenous Fluid Regime Effects on Immunological Indicators of Elderly Patients Operated for Abdominal Cancer Phase 3
Completed NCT02307253 - EUS GUIDED Transduodenal Biopsy Using the 19G Flex N/A
Completed NCT00186953 - Determination of a Safe Dose of Optison in Pediatric Patients With Solid Tumors Phase 1
Completed NCT03002909 - Continuous Pre-peritoneal Wound Infiltration Versus Epidural Analgesia in Cancer Surgery N/A
Recruiting NCT02557256 - Malignant Pediatric Pelvic Tumors: A Retrospective Study